ScholarIQanswers from OpenAlex & ORCID
Neal Rosen
ResearcherPublications, citations & collaboration network
Neal Rosen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Neal Rosen have?
ScholarIQindexed works
Neal Rosen has 1,009 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Neal Rosen have?
ScholarIQcitation count
Neal Rosen has 55,736 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Neal Rosen?
ScholarIQh-index
Neal Rosen has an h-index of 127 in OpenAlex.
What is the i10-index of Neal Rosen?
ScholarIQi10-index
Neal Rosen has an i10-index of 259 in OpenAlex.
What is the ORCID of Neal Rosen?
ScholarIQorcid
The ORCID for Neal Rosen is on the source record.
What is the OpenAlex record for Neal Rosen?
ScholarIQopenalex
The OpenAlex for Neal Rosen is on the source record.
What are the most-cited papers on Neal Rosen?
ScholarIQmost cited works
BRAF mutation predicts sensitivity to MEK inhibition
David B. Solit, Levi A. Garraway, Christine A. Pratilas, Ayana Sawai, Gad Getz, Andrea Basso, Qing Ye, Jose Lobo, Yuhong She, Iman Osman, Todd R. Golub, Judith S. Sebolt–Leopold, William R. Sellers, Neal Rosen
<sup>V600E</sup> BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway
Christine A. Pratilas, Barry S. Taylor, Qing Ye, Agnès Viale, Chris Sander, David B. Solit, Neal Rosen
Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
Piro Lito, Christine A. Pratilas, Eric W. Joseph, Madhavi Tadi, Ensar Halilovic, Matthew Zubrowski, Alan Huang, Wai Lin Wong, Margaret K. Callahan, Taha Merghoub, Jedd D. Wolchok, Elisa de Stanchina, Sarat Chandarlapaty, Poulikos I. Poulikakos, James A. Fagin, Neal Rosen
The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
Eric W. Joseph, Christine A. Pratilas, Poulikos I. Poulikakos, Madhavi Tadi, Weiqing Wang, Barry S. Taylor, Ensar Halilovic, Yogindra Persaud, Feng Xing, Agnès Viale, James Tsai, Paul B. Chapman, Gideon Bollag, David B. Solit, Neal Rosen
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer
Ana Bosch, Zhiqiang Li, Anna Bergamaschi, Haley Ellis, Eneda Toska, Aleix Prat, Jessica J. Tao, Daniel E. Spratt, Nerissa T. Viola, Pau Castel, Gerard Minuesa, Natasha Morse, Jordi Rodón, Yasir H. Ibrahim, Javier Cortés, José Manuel Pérez-García, Patricia Galván, Judit Grueso, Marta Guzmán, John A. Katzenellenbogen, Michael G. Kharas, Jason S. Lewis, Maura N. Dickler, Violeta Serra, Neal Rosen, Sarat Chandarlapaty, Maurizio Scaltriti, José Baselga